Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2023 / Oct / Balancing Care with Qnostics
Quality assurance and quality control

Balancing Care with Qnostics

How the Qnostics Control range tips the scales to benefit everyone in medicine

10/09/2023 2 min read

Share

With the advent of personalized medicine and increased technological advancement, the demands of today’s molecular diagnostic laboratories are high. Laboratory professionals must carefully balance standards, patient safeguarding, and quality of care – all while securing the best health outcomes.

Qnostics provides ballast for this difficult balancing act. With state-of-the-art quality control materials curated for the modern market, their solutions target an extensive range of infectious diseases, including respiratory diseases, transplant associated diseases, gastrointestinal diseases, sexually transmitted infections, central nervous system diseases and blood borne viruses – specifically for application with molecular methods.

Qnostics’ controls are highly accessible and provide many benefits for end users working in IVD manufacture, clinical research organizations, and clinical molecular diagnostic laboratories. Importantly, they are whole-pathogen, meaning they contain the full organism genome and mimic the performance of patient samples. Moreover, the controls effectively monitor the performance of the entire testing process, including extraction, amplification, and detection.

Notably, the samples provided are inactivated by irradiation and heat treatment for safe handling, before being liquid frozen to limit sample preparation time and offer stability for two years. Finally, because the controls are truly third party, they can provide independent assessment of assay performance while helping meet ISO 15189:2012 regulatory requirements, which makes them stand out among first party controls.

Benefits in brief:

  • Inactivated. Samples are irradiated and heat treated for safe handling.

  • Liquid frozen. Convenient and easy to use – simply thaw and run on the analyzer

  • Two-year stability.

  • Consolidation. Qnostics and Randox offer a full range of molecular controls for infectious disease testing, enabling consolidation to a single supplier.

  • Multi-analyte materials. Qnostics provide multi-analyte controls designed for use with multiplex assays, where appropriate.

  • Fully traceable. Organisms traceable to WHO standards wherever possible.

Qnostics’ Q Control range is designed to monitor molecular assay performance over time and can be applied for ongoing routine monitoring. Molecular Q Panels can be used to monitor the performance of quantitative assays, such as blood borne viruses and transplant related viral infections, across the clinical range. Analytical Q Panels and Evaluation Panels can be used for assay and instrument validation and verification, troubleshooting, and research and development.

Through the power of Qnostics, technicians are empowered to take control of the many variables in the lab – striking a better balance between precision and patient care.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

R-Tracker: The First of Its Kind
Quality assurance and quality control
R-Tracker: The First of Its Kind

December 29, 2021

1 min read

Milestone is committed to enhancing patient safety with a new disruptive technology

The Big Freeze
Quality assurance and quality control
The Big Freeze

February 7, 2022

1 min read

Cryobioprinting could maximize the shelf life of bioprinted 3D tissues

Biospecimen Access For Biotechs
Quality assurance and quality control
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Questions of Quality
Quality assurance and quality control
Questions of Quality

October 21, 2016

1 min read

The importance of quality is broadly accepted – witness the plethora of standards and guidelines – but do they lead to effective implementation?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.